Fintel reports that on May 23, 2025, Wells Fargo upgraded their outlook for Bicara Therapeutics (NasdaqGM:BCAX) from ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $190.3, a high estimate of $242.00 ...

Major United States (US) banks, including JPMorgan Chase, Bank of America, Citigroup and Wells Fargo, are eyeing a joint stablecoin venture amid a potential seismic shift in crypto regulations ...

The card features unlimited 2% cash back on all purchases, a sign-up bonus and a 0% intro APR promotion. When it comes to flat-rate cash-back cards, it's hard to beat 2% back, especially when the ...

Cardholders can rack up triple points across a wide swath of common spending categories like dining, travel, gas stations and streaming — all while paying no annual fee. This card offers ...

Economists at the financial institution weigh in on the improving commercial real estate market nationwide in a new report.

Analysts' ratings for Bruker BRKR -1.43% Get Free Report over the last quarter vary from bullish to bearish, as provided by 8 ...

This was the stock's third consecutive day of losses.

Co-hosted by Global Chamber's New York City and London chapters, the theme of the event is "Be AI-Ready – Strategizing for ...

ProShare Advisors LLC slashed its stake in Wells Fargo by a sharp 45.7% in the fourth quarter, parting with over 600,000 ...

Guidance for FY 2025 revenue growth increased to the midpoint of the 5%-7% target, up from the previous outlook at the low end of this range. Annual EPS growth is now guided slightly above the ...

Wells Fargo casts doubt on the emerging markets rally, citing structural challenges and past underperformance.